ROTIGOTINE IN THE TREATMENT OF HEMISPATIAL NEGLECT AND OTHER DEFICITS FOLLOWING STROKE

摘要

The present invention relates to the use of rotigotine for the effective treatment of a condition or disorder selected from neglect, stroke, conditions associated with stroke and/or following stroke. The invention also relates to a rotigotine-containing pharmaceutical composition, like a transepicutaneous pharmaceutical composition especially in the form of a transdermal therapeutic System (TTS).